ALW-II-41-27 structure
|
Common Name | ALW-II-41-27 | ||
---|---|---|---|---|
CAS Number | 1186206-79-0 | Molecular Weight | 607.68900 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C32H32F3N5O2S | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of ALW-II-41-27ALW-II-41-27 is a Eph family tyrosine kinase inhibitor with an IC50 of 11 nM for Eph2. |
Name | N-[5-[[4-[(4-ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]carbamoyl]-2-methylphenyl]-5-thiophen-2-ylpyridine-3-carboxamide |
---|---|
Synonym | More Synonyms |
Description | ALW-II-41-27 is a Eph family tyrosine kinase inhibitor with an IC50 of 11 nM for Eph2. |
---|---|
Related Catalog | |
Target |
IC50: 11 nM (Eph2)[1] |
In Vitro | ALW-II-41-27 inhibits Ba/F3 cells transformed with Tel fusions of EphA3, Kit, Fms, KDR, FLT1, FGR, Src, Lyn, Bmx, and Bcr-Abl with an EC50 below 500 nM. ALW-II-41-27 exhibits cross reactivity with Bcr-Abl. ALW-II-41-27 inhibits b-raf, CSF1R, DDR1, DDR2, EphA2, EphA5, EphA8, EphB1, EphB2, EphB3, Frk, Kit, Lck, p38α, p38β, PDGFRα, PDGFRβ, and Raf1 and many more demonstrating how introduction of the thiophene group can have a tremendous impact on kinase selectivity[1]. |
References |
Molecular Formula | C32H32F3N5O2S |
---|---|
Molecular Weight | 607.68900 |
Exact Mass | 607.22300 |
PSA | 112.79000 |
LogP | 7.42320 |
Storage condition | 2-8℃ |
Precursor 2 | |
---|---|
DownStream 0 |
hms2043h01 |
hms2218g07 |
cs-1203 |
alw-ii-41-27 |